Have a personal or library account? Click to login
Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model Cover

Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model

Endocrine Regulations
Volume 52 (2018): Issue 2 (April 2018)
By: Titin Andri Wihastuti,  Teuku Heriansyah,  Hanifa Hanifa,  Sri Andarini,  Zuhrotus Sholichah,  Yuni Hendrati Sulfia,  Aditya Angela Adam,  Jeki Refialdinata and  Nurul Cholifah Lutfiana  
Open Access
|Apr 2018
DOI: https://doi.org/10.2478/enr-2018-0008 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 69 - 75
Published on: Apr 30, 2018
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
darapladib,
atherosclerosis,
type 2 diabetes mellitus rat model
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2018 Titin Andri Wihastuti, Teuku Heriansyah, Hanifa Hanifa, Sri Andarini, Zuhrotus Sholichah, Yuni Hendrati Sulfia, Aditya Angela Adam, Jeki Refialdinata, Nurul Cholifah Lutfiana, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 52 (2018): Issue 2 (April 2018)Next article